BioSpace News Archive

Progenity, Inc. today announced a new patent related to its single-molecule detection platform under development.

Hygieia , a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from existing investors.

BD (Becton, Dickinson and Company) announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins.

ProMIS Neurosciences Inc. is pleased to announce shareholders passed the share consolidation resolution at its special general meeting of shareholders (the “ Special Meeting ”) held on December 1, 2021.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces today that it has begun production of the fourth generation of its specialized spider silk silkworms at its new production campus.

Zentalis Pharmaceuticals, Inc. is hosting a virtual R&D Day on December 16, 2021 from 11:00 a.m. to 12:00 p.m. EST.

XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), announces that it has appointed Altasciences as contract research organization (CRO) for its planned Bridging pharmacokinetic study in support of the XRx-008 program for autosomal dominant polycystic kidney disease (ADPKD) and XRx-101 for acute kidney injury associated with Coronavirus infection.

Prelude Corporation announced today it will be presenting new data on its ongoing prospective PREDICT study of DCIS patients at the 2021 San Antonio Breast Cancer Symposium (SABCS), being held on December 7 – 10 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

Southwest College of Naturopathic Medicine & Health Sciences (SCNM) is elated to introduce Dr. Michelle Cromwell as Vice President of Inclusive Excellence & Belonging (VPIEB) marking a pivotal advancement in the College’s history.

ELNA Medical is pleased to announce two additional key management appointments to support and accelerate its growth strategy across Canada.